Cellular and metabolic evaluation of (hydroxyproline(3))-GIP as new stable GIP receptor antagonist with antidiabetic potential

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)0661
JournalDiabetologia
Volume49
Issue numberSuppl.
Publication statusPublished - Sep 2006

Cite this